The Commission announced today that 8 large-scale research projects, aimed at developing treatments and diagnostics for the coronavirus, were selected in a fast-track call for proposals, launched in March by the Innovative Medicines Initiative (IMI), a public-private partnership.
In order to fund a larger number of high-quality proposals, the Commission increased its commitment to €72 million (up from the originally planned €45 million) from Horizon 2020, the EU's research and innovation programme.
